Status:
COMPLETED
The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients
Lead Sponsor:
Eskisehir Osmangazi University
Collaborating Sponsors:
Koç University
Conditions:
Ankylosing Spondylitis
Spondylitis, Ankylosing
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study was carried out to develop an android mobile application for the subcutaneous (SC) anti-TNF drug administration of ankylosing spondylitis patients and to evaluate its effect on drug adminis...
Detailed Description
Ankylosing spondylitis is a chronic, inflammatory disease that affects the axial spine, causing progressive limitation on the spine and leading to a decrease in quality of life. Anti TNF drugs are fre...
Eligibility Criteria
Inclusion
- are diagnosed with ankylosing spondylitis according to the New York modification criterias
- administer anti-TNF agent for the first or second time
- are 18 years old and had literacy
- have an android phone,
- can use the andriod phone,
- agree to participate in the work
Exclusion
- refuse to participate in the study
- be young than 18 years old
- administer anti-TNF agent more than twice
Key Trial Info
Start Date :
December 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04301128
Start Date
December 27 2017
End Date
December 31 2019
Last Update
October 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eskişehir Osmangazi University Faculty of Health Sciences
Eskişehir, Eskişehir, Turkey (Türkiye), 26480